Meridian Bioscience reported $4.65M in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US USD 1.77B 602M
Atrion ATRI:US USD 11.03M 3.19M
Becton, Dickinson and BDX:US USD 490M 45M
Bio Rad Laboratories BIO:US USD 92.8M 27.42M
Meridian Bioscience VIVO:US USD 4.65M 11.33M
Myriad Genetics MYGN:US USD -45000000 27.2M
Neogen NEOG:US USD -7656000 13.72M
Orasure Technologies OSUR:US USD 875K 22.16M
Rockwell Medical RMTI:US USD -3708000 774K
Thermo Fisher Scientific TMO:US USD 1.71B 291M